Drug intelligence / Profile preview

NuA3

Development stage
Unknown
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

The NuA3 histone acetyltransferase complex is a multi-subunit protein complex primarily studied in budding yeast (Saccharomyces cerevisiae). It functions as an enzyme that specifically acetylates lysine 14 on histone H3 (H3K14), an epigenetic modification crucial for regulating various biological processes, including gene transcription, cell cycle control, and DNA repair. The complex is composed of several subunits, such as the catalytic subunit Sas3 and the non-catalytic subunit Nto1, which cooperatively form a histone tail-binding cleft. NuA3's targeting and activity are influenced by its interactions with other histone modifications, including binding to H3K4me3 via its Yng1 subunit and H3K36me3 via its Pdp3 subunit. Furthermore, NuA3 antagonizes the activity of histone deacetylases like Rpd3S and Rpd3L, contributing to the dynamic regulation of histone acetylation and gene expression.

02

Targets

H3K4me3-H3K36me3 (Histone H3 tail trimethylated at Lysine 4 and Lysine 36)

Beyond the preview

Go deeper on NuA3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuA3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call